ARYEX | CREFX | ARYEX / CREFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 8 years | - |
Gain YTD | 11.375 | 10.398 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 704M | 8.38B | 8% |
Annual Yield % from dividends | 2.61 | 3.03 | 86% |
Returns for 1 year | 13.05 | 12.01 | 109% |
Returns for 3 years | -18.43 | -7.23 | 255% |
Returns for 5 years | -4.23 | 19.24 | -22% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DVSMX | 24.87 | N/A | N/A |
Driehaus Small Cap Growth Investor | |||
TIHAX | 12.29 | N/A | N/A |
Transamerica International Stock A | |||
BIPSX | 39.51 | -0.14 | -0.35% |
ProFunds Biotechnology UltraSector Svc | |||
FTGRX | 25.88 | -0.13 | -0.50% |
Fidelity Advisor Mega Cap Stock M | |||
RAFCX | 42.01 | -2.79 | -6.24% |
American Funds AMCAP R3 |